Bone Marrow DCE-MRI Prediction of Acute Leukemia Response to Therapy
Aneela Afzal 1 , Xin Li 1 , Mohan Jayatilake 1 , Yiyi Chen 1 , Zunqiu Chen 1 , William Woodward 1 , William Fleming 1 , and Wei Huang 1
Oregon Health & Science University,
Portland, Oregon, United States
Pre-chemotherapy DCE-MRI exams were performed on 13
acute myelogenous leukemia (AML) patients. The mean bone
marrow kep parameter from vertebral body (L2 - L4) and
iliac crest provided excellect prediction of complete
remission status after the chemotherapy. Bone marrow DCE-MRI
may be a useful noninvasive imaging tool in personalized
care of leukemia patient.
This abstract and the presentation materials are available to members only;
a login is required.